ArticleCancers2019

Tumor BRCA Test for Patients with Epithelial Ovarian Cancer: The Role of Molecular Pathology in the Era of PARP Inhibitor Therapy.

Caterina Fumagalli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.